Volume 14, Number 7—July 2008
Perspective
Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe
Table
Leishmaniasis situation in 7 disease-endemic countries of Europe (including Turkey)*
Country | Human leishmaniasis |
Canine leishmaniasis | |||
---|---|---|---|---|---|
Notification status | Current information from reference centers (2000–2006) | VL + CL incidence x 100,000† | Imported cases (VL + CL) | ||
Portugal‡ | Compulsory for VL | ≈22 VL cases/y recorded at IHMT | 0.07–0.17 | ≈2 cases/y recorded at IHMT | Average 20% seroprevalence in disease-endemic areas (3) |
Spain§ | Compulsory in 12/17 autonomous communities; 20%–45% underreporting for VL, ≈100% for CL (4) | ≈100 VL cases/y recorded by National Epidemiologic Surveillance Network, RENAVE | 0.18–0.29 | ≈5 cases/y recorded at ISCIII | Average 8.5% seroprevalence (5) |
France¶ | Not compulsory, but spontaneous reports at UMON | ≈24 VL + CL cases/y reported at UMON | 0.02–0.19 | ≈65 cases/y recorded at UMON | Seroprevalence in disease-endemic areas of southern France 4%–20%# |
Italy** | Compulsory for both VL and CL, but CL underreported | ≈200 VL cases/y recorded at ISS; ≈300 CL cases/y estimated by ISS | 0.15–0.38 | ≈8 cases/y recorded at ISS | Average 15% seroprevalence in peninsular Italy; average 2% seroprevalence in continental Italy (6) |
Greece†† | Compulsory for both VL and CL, but underreported | ≈21 VL cases/y notified | 0.06–0.49 | Unknown | Average seroprevalence 25% in disease-endemic areas (7) |
Cyprus‡‡ | Compulsory for both VL and CL, but underreported | 5 VL + CL cases recorded in 2006 | 0.25–0.47 | Unknown | Average seroprevalence 20% in disease-endemic areas |
Turkey§§ | Compulsory for both VL and CL | ≈37 VL cases/y and ≈2,300 CL cases/y notified | 1.6–8.53 | Unknown | Average 15.7% seroprevalence |
*Authors’ institutions are national reference laboratories for leishmaniasis diagnosis and surveillance and rely on consolidated countrywide networks of collaborating clinical health centers. Diagnosis records are cross-checked with case notifications to provide more realistic figures and estimates. VL, visceral leishmaniasis; CL, cutaneous Leishmaniasis; WHO, World Health Organization.
†WHO-EURO, WHO Europe, 1996–2005; http://data.euro.who.int/CISID.
‡Instituto de Higiene e Medicina Tropical (IHMT), Lisbon, Portugal.
§Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
¶Université de Montpellier (UMON), data from Centre National de Référence des Leishmania, Montpellier, France.
#Source: retrospective canine leishmaniasis database, Centre National de Référence des Leishmania.
**Istituto Superiore di Sanità (ISS), Rome, Italy.
††Hellenic Pasteur Institute (HPI), Athens, Greece.
‡‡National Reference Laboratory for Animal Health (VS), Nicosia, Cyprus.
§§Ege University (EUMS-DP), Izmir, Turkey.
References
- Cortes S, Afonso MO, Alves-Pires C, Campino L. Stray dogs and leishmaniasis in urban areas, Portugal. Emerg Infect Dis. 2007;13:1431–2.PubMed
- Alvar J. Las leishmaniasis: de la biología al control, 2001. Salamanca: Laboratorios Intervet S.A.; 2001.
- Miró G, Molina R. Leishmaniosis canina: Manejo clínico y situación actual en España, 2006. Spain: Bayer Health Care; 2006
- Gradoni L. Epizootiology of canine leishmaniasis in southern Europe. In: R. Killick-Kendrick, editor. Canine leishmaniasis: an update. Wiesbaden (Germany): Hoechst Roussel Vet; 1999. p. 32–9.
- Maroli M, Rossi L, Baldelli R, Capelli G, Ferroglio E, Genchi C, The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop Med Int Health. 2008;13:256–64.PubMed
- Malik ANJ, John L, Bryceson ADM, Lockwood DNJ. Changing pattern of visceral leishmaniasis, United Kingdom, 1985–2004. Emerg Infect Dis. 2006;12:1257–9.PubMed
- Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol. 1999;37:1953–7.PubMed
- Afonso MO, Campino L, Cortes S, Alves-Pires C. The phlebotomine sandflies of Portugal. XIII–Occurrence of Phlebotomus sergenti Parrot, 1917 in the Arrabida leishmaniasis focus. Parasite. 2005;12:69–72.PubMed
- Depaquit J, Léger N, Ferté H, Rioux JA, Gantier JC, Michaelides A, Phlebotomines of the Isle of Cyprus. III. Species inventory. Parasite. 2001;8:11–20.PubMed
- Garifallou A, Schnur LF, Stratigos JD, Hadziandoniou M, Savigos M, Stavrianeas N, Leishmaniasis in Greece II. Isolation and identification of the parasite causing cutaneous leishmaniasis in man. Ann Trop Med Parasitol. 1984;78:369–75.PubMed
- Miles MA, Vexenat JA, Furtado Campos JH, Fonseca de Castro JA. Canine leishmaniasis in Latin America: control strategies for visceral leishmaniasis. In: R. Killick-Kendrick, editor. Canine leishmaniasis: an update. Barcelona: Hoechst Roussel Vet;1999. p. 46–53.
- World Health Organization. Eighteenth programme report/progress 2005–2006. Geneva: The Organization; 2007.
- World Health Organization. Report of the fifth Consultative Meeting on HIV-Leishmania Co-Infection, Addis Ababa 20–22 March 2007. Geneva: The Organization; 2007.
- Capelli G, Baldelli R, Ferroglio E, Genchi C, Gradoni L, Gramiccia M, Monitoring of canine leishmaniasis in northern Italy: an update from a scientific network. Parassitologia. 2004;46:193–7.PubMed